Workflow
Allergic and Inflammatory Diseases
icon
Search documents
Blueprint Medicines(BPMC) - 2025 Q1 - Earnings Call Transcript
2025-05-01 13:02
Blueprint Medicines (BPMC) Q1 2025 Earnings Call May 01, 2025 08:00 AM ET Company Participants Jenna Cohen - Vice President of Investor Relations and Global Business CommunicationsKate Haviland - President & CEOPhilina Lee - Chief Commercial OfficerBecker Hewes - Chief Medical OfficerMike Landsittel - Chief Financial OfficerLaura Prendergast - Vice PresidentChristina Rossi - Chief Operating OfficerPaul Jeng - Vice PresidentMichael Yee - Managing DirectorMark Aleynick - Biotechnology Equity ResearchReni Benj ...
Blueprint Medicines(BPMC) - 2025 Q1 - Earnings Call Transcript
2025-05-01 12:00
Blueprint Medicines (BPMC) Q1 2025 Earnings Call May 01, 2025 08:00 AM ET Speaker0 Good morning. My name is Angela Lang, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicines' First Q twenty twenty five Earnings Release and Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer Thank you. Jenna Cohen, you may begin your conference. Speaker1 Thank you, ...